ACE2 and COVID-19: Surprisingly, controversial results have been published about the level of soluble ACE2; elevated activity values with a strong correlation with disease severity and outcome were described in many clinical studies [19,20,21,22,23,24], while unchanged levels [25,26] or even lower quantities [27] were explored in groups of severe COVID-19 patients.